Business
Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call
Oslo, Norway, 5 February 2026 Vistin Pharma ASA will release its fourth quarter and preliminary 2025 results on Thursday 12th of February 2025. Vistin Pharma will host a conference call for all shareholders and interested parties on the same day at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The fourth quarter conference call will be available via web and audio through the following access points: Webcast: https://edge.
About this update from Vistin Pharma Asa
[{"type":"image","alt":"Vistin Pharma ASA","displaySize":"","headline":null,"caption":"Vistin Pharma ASA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":140,"url":"https://media.zenfs.com/en/globenewswire.com/ac8aa8cffa4cdd54adc69f5141a335bf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NkKrHG5t6cerGaG2Lk6dkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5NjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ac8aa8cffa4cdd54adc69f5141a335bf","width":300,"height":140}},"lazy":false},{"type":"text","content":"Oslo, Norway, 5 February 2026","length":29,"tagName":"p"},{"type":"text","content":"Vistin Pharma ASA will release its fourth quarter and preliminary 2025 results on Thursday 12th of February 2025. Vistin Pharma will host a conference call for all shareholders and interested parties on the same day at 08:30 CET. There will be a Q&A session following the management discussion.","length":298,"tagName":"p"},{"type":"text","content":"The conference call will be held in English.","length":44,"tagName":"p"},{"type":"text","content":"The fourth quarter conference call will be available via web and audio through the following access points:","length":107,"tagName":"p"},{"type":"text","content":"Webcast: https://edge.media-server.com/mmc/p/fuobg9oe","length":53,"tagName":"p"},{"type":"text","content":"Telephone conference (online registration): https://register-conf.media-server.com/register/BI64a611c39d97475c8ddf70bb07d2a9b6","length":127,"tagName":"p"},{"type":"text","content":"*****","length":5,"tagName":"p"},{"type":"text","content":"For further information, please contact:","length":40,"tagName":"p"},{"type":"text","content":"Alexander KarlsenCFO+47 [email protected]","length":63,"tagName":"p"},{"type":"text","content":"About Vistin Pharma | www.vistin.com","length":36,"tagName":"p"},{"type":"text","content":"Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.","length":434,"tagName":"p"},{"type":"text","content":"","l...